Subantimicrobial-dose doxycycline monohydrate in dermatology.

about

Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation.Otophyma, Rhinophyma and Telangiectatic Rosacea - A Rare Combination in a Female Patient.

P2860

Q36274684-EE3364DC-FA7E-4E44-9235-2B5BA32DAFE8 Q41179857-802AB66C-1144-4B65-9007-06786B289D26

P2860

Subantimicrobial-dose doxycycline monohydrate in dermatology.

Item

http://www.wikidata.org/entity/Q46639991

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Subantimicrobial-dose doxycycline monohydrate in dermatology.

@en

Subantimicrobial-dose doxycycline monohydrate in dermatology.

@nl

type

Item

label

Subantimicrobial-dose doxycycline monohydrate in dermatology.

@en

Subantimicrobial-dose doxycycline monohydrate in dermatology.

@nl

prefLabel

Subantimicrobial-dose doxycycline monohydrate in dermatology.

@en

Subantimicrobial-dose doxycycline monohydrate in dermatology.

@nl

P1476

Subantimicrobial-dose doxycycline monohydrate in dermatology

@en

P2093

Uwe Wollina

http://www.w3.org/2001/XMLSchema#string

P2860

Perioral dermatitis: a review of the condition with special attention to treatment options

Recent advances in the understanding and management of rosacea.

Rosacea and rhinophyma: not curse of the Celts but Indo Eurasians.

Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma

Update on rosacea and anti-inflammatory-dose doxycycline.

Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action.

Retarded low-dose doxycycline for EGFR or MEK inhibitor-induced papulopustular rash.

Cutaneous adverse effects of targeted therapies: Part I: Inhibitors of the cellular membrane.

Cutaneous adverse effects of targeted therapies: Part II: Inhibitors of intracellular molecular signaling pathways.

Anti-inflammatory properties of low and high doxycycline doses: an in vitro study.

P2888

s10354-015-0399-9

P304

499-503

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10354-015-0399-9

http://www.w3.org/2001/XMLSchema#string

P433

23-24

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P50

Uwe Wollina

P577

2015-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26564206

http://www.w3.org/2001/XMLSchema#string

Subantimicrobial-dose doxycycline monohydrate in dermatology.

about

P2860

P2860

Subantimicrobial-dose doxycycline monohydrate in dermatology.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698